LA Jolla Pharmaceutical Revenue, Growth & Competitor Profile

DBA LA JOLLA PHARMACEUTICAL COMPAN

Company Profile & Annual Report for LA Jolla Pharmaceutical

Access the complete profile.

LA Jolla Pharmaceutical Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	201 Jones Rd Ste 400 Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


LA Jolla Pharmaceutical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • LA Jolla Pharmaceutical's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • LA Jolla Pharmaceutical is classified as operating in the Legal Services industry, NAICS Code 5411.

LA Jolla Pharmaceutical Annual Revenue and Growth Rate

LA Jolla Pharmaceutical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: LA Jolla Pharmaceutical's revenues are gauged from an analysis of company filings.

LA Jolla Pharmaceutical's Income Statement (based on Industry Averages)

LA Jolla Pharmaceutical P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that LA Jolla Pharmaceutical is developing and marketing. LA Jolla Pharmaceutical doesn't have any recent trademark applications, indicating LA Jolla Pharmaceutical is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GIOVIQ Pharmaceuticals for the treatment of hypotension; antihypotensive agents	08/16/2017
LA JOLLA PHARMACEUTICAL house mark for pharmaceutical products for human use, namely, pharmaceuticals for the treatment of hypotension and antihypotensive agents	01/25/2017
LJPC House mark for pharmaceutical products for human use	01/25/2017

See all trademarks and details in the Full Report.

Market Share of LA Jolla Pharmaceutical's Largest Competitors

A competitive analysis shows these companies are in the same general field as LA Jolla Pharmaceutical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to LA Jolla Pharmaceutical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MORSE BARNES-BROWN & PENDLETON P.C.	Waltham, MA	100
FABER DAEUFER & ITRATO PC	Waltham, MA	80
LIGRIS & ASSOCIATES PC	Newton, MA	72
CUSHING & DOLAN P.C.	Waltham, MA	60
KAJKO WEISMAN & COLASANTI	Lexington, MA	59
HARMON LAW OFFICES P.C.	Newton, MA	59

Future Competition: LA Jolla Pharmaceutical's Fastest Growing Competitors

These companies are in the same general field as LA Jolla Pharmaceutical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)